INTERVIEWS

Dr. Sean Boynes, DMD, MS, Vice President of Health Improvement at DentaQuest discusses teledentistry an unexpected outcome of the COVID-19 pandemic. 

Eleusis is a clinical-stage life science company that has two lines of business:  a traditional drug development arm called Eleusis Therapeutics, and a care delivery platform called Eleusis Health Solutions.  Here to discuss the company and the potential and power of psychedelic medicine in treating chronic inflammatory disease, mental health, and Alzheimer’s is CEO, founder, and chairman, Shlomi Raz.

Founder and CEO of Miiskin Jon Friis discusses the partnership between the Skin Cancer Foundation and Miiskin for Skin Cancer Awareness Month to remind people to perform self-skin exams.  Miiskin is a digital health platform supported by the dermatological community as a tool to help track skin changes.

Bonnie J. Addario, Co-Founder, Board Chair, GO2 Foundation for Lung Cancer discusses the foundation along with other patient advocacy group’s support of Guardant Health’s “Clear Your View” campaign to bring awareness around comprehensive genomic testing for patients with metastatic non-small cell lung cancer (NSCLC) before first-line treatment.

Dr. Benjamin Levy, Division Head Of Gastroenterology at Mount Sinai Hospital in Chicago, discusses the impact the pandemic has had on colorectal cancer screening and diagnostics, the expected backlog when offices open back up, and the role at-home tests (like Cologuard®) can play to filter the right people into diagnostic screening.

Radiologist, Dr. Doug Beall, MD, from the Oklahoma Spine Hospital, discusses ways to educate patients about PMO, the connection to fractures, and current treatment options.

Dr. Suzanne Steinbaum, a cardiologist, discusses the controversy between women and statins, best practices on how women with a full plate of responsibilities can still prioritize their health, and how she maintains open relationships with her patients in this new virtual landscape.

Dr. Linda Marbán, President, CEO and Director of Capricor Therapeutics discusses new data reporting 100 percent survival in critical COVID-19 patients that were treated with her team’s off-the-shelf, cardiac cell therapy CAP-1002. These patients were part of six compassionate care cases treated at Cedars-Sinai Medical Center in Los Angeles, and following a review of the data, the FDA approved the company’s expanded access protocol to treat additional COVID-19 patients with this novel new therapeutic.

Kate Drake, Head of Product Marketing with Corindus, a Siemens Healthineers Company, discusses the CorPath® GRX  robotic system that was developed to make complex heart and brain procedures safer for patients and physicians by limiting radiation exposure and making physician movements more precise, but it can also be operated remotely.  Currently, physicians will control the robot while seated across the room, but a cardiologist in India successfully performed five heart procedures in 2018 while controlling the robot over a hardwired internet connection from 20 miles away.  Robotic-assisted procedures are turning out to be very beneficial during the pandemic.

With more patients turning to home exercise there has been a rise in foot injuries.  Dr. Kyle Kinmon, a leading podiatrist in South Florida discusses how patients can seek specialized treatment if they are uncomfortable going to the doctor’s office, what people experiencing foot/ankle issues should do and when to know if they have to be seen by a specialist, and what to do to prevent foot complications.